Scientists at the Karolinska Institute have discovered drugs that reduce mortality among patients with coronavirus. These drugs are cholesterol-fighting drugs, writes The Times.
Experts conducted a study in Sweden, which involved about a million people aged 45 and over. Doctors analyzed information about drugs taken by patients, as well as information from the register of causes of death.
As a result of the study, scientists called statins drugs that lower not only cholesterol levels, but also mortality from COVID-19. Experts said that patients who receive them are less likely to die with coronavirus. In addition, statins help reduce inflammation in the blood vessels.
“Overall, our results confirm the continued use of statins in cases such as cardiovascular disease and high blood lipids in line with current guidelines during the COVID-19 pandemic,” said one of the article’s authors, Viktor Alqvist.
However, the scientists noted that the results of their study were not enough to come to accurate conclusions about a causal relationship between statin use and the reduction in mortality from coronavirus.
Earlier, American scientists explained the high mortality rate from coronavirus. The most likely reason for this is the excessive accumulation of SARS-CoV-2 particles in the lungs of patients.